EuroAPI has agreed to acquire BianoGMP, a CDMO focused on small-scale, early-stage oligonucleotides, for about €10 million. The deal is expected to close in Q4. Created in 2017 by Professor Tobias Pöhlmann and Dr Rolf Günther, Biano is based in Gera, Germany, with a client base in Europe and Asia.